Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Carlier

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Cancers|September 9, 2020
Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III TrialsAnne-Victoire Michaud-Robert, Elena Zamagni, Thomas Carlier, et al.
International Journal of Molecular Sciences|February 21, 2017
PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma PatientsClément Bailly, Rodolphe Leforestier, Bastien Jamet, et al.
Physics in Medicine and Biology|March 23, 2023
Design of a generic method for single dual-tracer PET imaging acquisition in clinical routineNasrin Taheri, Benjamin Le Crom, Caroline Bouillot, et al.
Cancers|August 30, 2020
Usefulness of FDG-PET/CT-Based Radiomics for the Characterization and Genetic Orientation of Pheochromocytomas Before SurgeryCatherine Ansquer, Delphine Drui, Eric Mirallié, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 11, 2024
DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET/MRI imaging approachBastien Jamet, Hatem Necib, Thomas Carlier, et al.
International Journal of Molecular Sciences|December 31, 2016
Immuno-PET for Clinical Theranostic ApproachesClément Bailly, Pierre-François Cléry, Alain Faivre-Chauvet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2012
Differences in the biologic activity of 2 novel MEK inhibitors revealed by 18F-FDG PET: analysis of imaging data from 2 phase I trialsFrançoise Kraeber-Bodéré, Thomas Carlier, Valérie Meresse Naegelen, et al.
Frontiers in Medicine|April 27, 2019
Interest of Pet Imaging in Multiple MyelomaBastien Jamet, Clément Bailly, Thomas Carlier, et al.
Cancers|June 10, 2020
ImmunoPET in Multiple Myeloma-What? So What? Now What?Clément Bailly, Benjamin Chalopin, Sébastien Gouard, et al.
ACS Applied Materials & Interfaces|October 20, 2015
Lead-Free α-La₂WO₆ Ferroelectric Thin FilmsThomas Carlier, Marie-Hélène Chambrier, Anthony Ferri, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Cancers|September 9, 2020
Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III TrialsAnne-Victoire Michaud-Robert, Elena Zamagni, Thomas Carlier, et al.
International Journal of Molecular Sciences|February 21, 2017
PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma PatientsClément Bailly, Rodolphe Leforestier, Bastien Jamet, et al.
Physics in Medicine and Biology|March 23, 2023
Design of a generic method for single dual-tracer PET imaging acquisition in clinical routineNasrin Taheri, Benjamin Le Crom, Caroline Bouillot, et al.
Cancers|August 30, 2020
Usefulness of FDG-PET/CT-Based Radiomics for the Characterization and Genetic Orientation of Pheochromocytomas Before SurgeryCatherine Ansquer, Delphine Drui, Eric Mirallié, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 11, 2024
DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET/MRI imaging approachBastien Jamet, Hatem Necib, Thomas Carlier, et al.
International Journal of Molecular Sciences|December 31, 2016
Immuno-PET for Clinical Theranostic ApproachesClément Bailly, Pierre-François Cléry, Alain Faivre-Chauvet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2012
Differences in the biologic activity of 2 novel MEK inhibitors revealed by 18F-FDG PET: analysis of imaging data from 2 phase I trialsFrançoise Kraeber-Bodéré, Thomas Carlier, Valérie Meresse Naegelen, et al.
Frontiers in Medicine|April 27, 2019
Interest of Pet Imaging in Multiple MyelomaBastien Jamet, Clément Bailly, Thomas Carlier, et al.
Cancers|June 10, 2020
ImmunoPET in Multiple Myeloma-What? So What? Now What?Clément Bailly, Benjamin Chalopin, Sébastien Gouard, et al.
ACS Applied Materials & Interfaces|October 20, 2015
Lead-Free α-La₂WO₆ Ferroelectric Thin FilmsThomas Carlier, Marie-Hélène Chambrier, Anthony Ferri, et al.
Pageof 9